Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Boston Beer Company Inc (SAM) Price & Performance

BioNTech SE - ADRTrade
Boston Beer Company IncTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Boston Beer Company Inc — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.78B), while Boston Beer Company Inc trades at $168.61 (market cap $1.80B). The key difference: BioNTech SE - ADR is far larger — about 12.7× Boston Beer Company Inc's market cap. Which is the better fit depends on your goals.

BNTXSAM
Market Cap
$22.78B$1.80B
Sector
HealthConsumer Staples
52-Week High
$119.34$260.05
52-Week Low
$83.89$161.08
Enterprise Value
$6.45B$1.67B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Boston Beer Company Inc

Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.

Read more on SAM